NextFin News - In a landmark development for digital health, Eka Care, a prominent Indian health-tech firm, announced on February 18, 2026, a strategic collaboration with NVIDIA to build a next-generation AI-powered medical scribe. This initiative aims to create a unified, multilingual model capable of operating entirely offline, a breakthrough designed to bring advanced clinical documentation to remote and resource-constrained clinics across India. The announcement, made during the India–AI Impact Summit 2026 in New Delhi, highlights a "sovereignty-first" approach to healthcare technology, ensuring that sensitive patient data remains on-device rather than being processed in the cloud.
According to BW Healthcare World, the partnership leverages NVIDIA’s comprehensive AI software stack and accelerated computing infrastructure to solve the unique challenges of the Indian medical landscape. Eka Care is utilizing NVIDIA NeMo Curator to clean and organize vast datasets of Indian medical conversations, ensuring high data hygiene for model training. To address the technical hurdle of "catastrophic forgetting"—where AI loses prior knowledge when learning new tasks—the team is integrating the NVIDIA Nemotron CC dataset. This replay-based training method allows the model to maintain general linguistic fluency while specializing in complex, localized medical terminology and diverse Indian accents.
The technical architecture of the scribe is particularly ambitious. Eka Care is evaluating NVIDIA Nemotron Speech models, including Parakeet automated speech recognition (ASR), to merge transcription and large language model (LLM) capabilities into a single, efficient framework. This consolidation is intended to reduce computational overhead, allowing the AI to run on a doctor’s mobile device with low latency. Vikalp Sahni, Founder and CEO of Eka Care, emphasized that the model must navigate complex "code-mixing"—the common practice in India of blending English with regional languages—to be truly effective in a clinical setting.
From an analytical perspective, this partnership represents a significant pivot toward edge computing in the healthcare sector. By moving AI processing from the cloud to the device, Eka Care and NVIDIA are addressing the primary deterrents to AI adoption in medicine: data privacy and unreliable internet connectivity. In rural India, where broadband penetration remains uneven, an offline scribe ensures that the administrative burden on physicians—which can consume up to 40% of their workday—is reduced regardless of infrastructure quality. This "sovereignty-first" model aligns with the broader goals of the IndiaAI Mission, which seeks to build indigenous AI capabilities that are not dependent on foreign cloud providers.
The economic implications are equally profound. By reducing the time doctors spend on manual documentation, the AI scribe effectively increases the throughput of the healthcare system. Data from the India–AI Impact Summit suggests that AI-driven administrative tools could contribute significantly to India’s goal of adding $500 billion to its GDP through AI by 2030. Furthermore, Sahni’s indication that parts of the model may be open-sourced suggests a strategy to foster a broader ecosystem of clinical AI applications, potentially standardizing how medical data is captured and structured across the country.
Looking ahead, the success of this collaboration will likely trigger a wave of similar "offline-first" AI initiatives in other emerging markets. As NVIDIA continues to expand its footprint through programs like NVIDIA Inception, the focus is shifting from general-purpose LLMs to highly specialized, domain-specific models. Tobias Halloran, Director at NVIDIA, noted that India’s startup ecosystem is uniquely positioned to lead this trend due to its technical talent and the sheer scale of its data diversity. The Eka Care-NVIDIA alliance serves as a blueprint for how global technology giants and local innovators can co-develop solutions that are both technologically sophisticated and culturally relevant, ultimately democratizing access to high-quality healthcare documentation.
Explore more exclusive insights at nextfin.ai.
